- Home
- Publications
- Publication Search
- Publication Details
Title
The TNF Paradox in Cancer Progression and Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-31
DOI
10.3389/fimmu.2019.01818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGF-β1 and TNF-α synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation
- (2019) Sheng-Jun Liao et al. Journal of Cell Communication and Signaling
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma
- (2019) Candice Lesage et al. JOURNAL OF IMMUNOTHERAPY
- Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death
- (2018) Tsadik Habtetsion et al. Cell Metabolism
- Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy
- (2018) Angela Rita Elia et al. CLINICAL CANCER RESEARCH
- Immunotherapy Resistance by Inflammation-Induced Dedifferentiation
- (2018) Arnav Mehta et al. Cancer Discovery
- TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
- (2018) V. Cervera-Carrascon et al. OncoImmunology
- Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine
- (2018) Philipp Probst et al. CLINICAL CANCER RESEARCH
- Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs
- (2018) Arianna Draghi et al. INTERNATIONAL JOURNAL OF CANCER
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
- (2017) Florie Bertrand et al. Nature Communications
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Blocking Tumor Necrosis Factor Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma
- (2015) F. Bertrand et al. CANCER RESEARCH
- Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity
- (2015) Marco Donia et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transition Induced by TNF- Requires NF- B-Mediated Transcriptional Upregulation of Twist1
- (2012) C.-W. Li et al. CANCER RESEARCH
- TNF signaling drives myeloid-derived suppressor cell accumulation
- (2012) Xueqiang Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting TNF- to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy
- (2012) A. Calcinotto et al. JOURNAL OF IMMUNOLOGY
- TNF- Induces Epithelial-Mesenchymal Transition of Renal Cell Carcinoma Cells via a GSK3 -Dependent Mechanism
- (2012) M.-Y. Ho et al. MOLECULAR CANCER RESEARCH
- Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
- (2012) Jennifer Landsberg et al. NATURE
- B regulatory cells and the tumor-promoting actions of TNF- during squamous carcinogenesis
- (2011) T. Schioppa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
- (2009) Kellie A. Charles et al. JOURNAL OF CLINICAL INVESTIGATION
- A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer
- (2008) E. R. Brown et al. ANNALS OF ONCOLOGY
- Low Levels of Tumor Necrosis Factor Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site
- (2008) B. Li et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started